Mentions
Extended reach
Total likes
Video views
AI synopsis
The social discussions reflect a strong interest and concern about the variability in MDMA content and dissolution rates, with phrases like 'worrying MDMA facts' and mentions of the unpredictability of effects, which underscores the potential health risks and need for regulation. The tone and choice of words convey a sense of urgency and importance, aligning with the higher scores in interest and impact.
Most discussions acknowledge the study’s findings about MDMA variability and agree on the potential health risks posed to users, indicated by phrases like 'worrying MDMA facts' and discussions of public health concerns.
The social discussions demonstrate high interest, with reactions highlighting the significance of the findings and raising questions about regulation and safety, reflecting curiosity and concern.
Multiple posts delve into details such as variability within batches, effects on users, and implications for regulation, showing deep engagement with the research and its implications.
The discussions emphasize the practical health and safety impacts, suggesting that the findings could influence drug regulation policies and harm reduction strategies, indicating high perceived impact.
The high demand for ecstasy tablets, professional drug checking services, & other quality control measures have resulted in high-content tablets produced/sold in EU countries. Varying content & dissolution profiles put PWUD at risk, regulation could help! https://t.co/NBGyfTGuOC
This study addresses an important question I have thinking of a lot. Ecstasy tablets from a same batch could not contain the same amount of MDMA because the illicit nature of their production (lack of quality control). https://t.co/LoNp55mMGv https://t.co/1oBTnPWigQ
New drug-testing paper: a lot of variability in dosage and release time within single batches of MDMA/ecstasy. Therefore, doses from the same batch may have different effects https://t.co/rzPvu0Ba9I https://t.co/ktZ3og2HgV
Variability in content and dissolution profiles of #MDMA tablets collected in the UK between 2001 and 2018 - A potential risk to users? [a] https://t.co/3NfxI9DFJa HT Pharmaceutical Sciences Clinical Academic Group @kingscollegelon #SUD #PWUD #Ecstasy https://t.co/Un6Hesi4np
Variability in content and dissolution profiles of #MDMA tablets collected in the UK between 2001 and 2018 - A potential risk to users? [a] https://t.co/3NfxI9DFJa HT Pharmaceutical Sciences Clinical Academic Group @kingscollegelon #SUD #PWUD #Ecstasy https://t.co/P82KpvIrtQ
RT @maier_larissa: The high demand for ecstasy tablets, professional drug checking services, & other quality control measures have resulted…
Ecstasy is known as a recreational drug that can cause feelings of happiness and love. However, in some cases, overdose from MDMA can lead to life-threatening conditions, especially due to high doses or contaminated…
Ecstasy is often seen as a feel-good drug, but overdose can cause severe, life-threatening conditions. Analyses show many pills contain high and variable doses of active substances, increasing overdose risk and…
This study compares UK data with other countries to address public health authorities' concerns over the prevalence of 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) tablets.
Variability in content and dissolution profiles of #MDMA tablets collected in the UK between 2001 and 2018 - A potential risk to users? [a] https://t.co/3NfxI9DFJa HT Pharmaceutical Sciences Clinical Academic Group @kingscollegelon #SUD #PWUD #Ecstasy https://t.co/Un6Hesi4np
Variability in content and dissolution profiles of #MDMA tablets collected in the UK between 2001 and 2018 - A potential risk to users? [a] https://t.co/3NfxI9DFJa HT Pharmaceutical Sciences Clinical Academic Group @kingscollegelon #SUD #PWUD #Ecstasy https://t.co/P82KpvIrtQ
ASI's pioneering research flags worrying MDMA facts:- 1 Concentration of MDMA in tablets is going up. 2 Tablets from the same batch can vary in MDMA content by up to 250%. 3 Tablets from the same batch can release MDMA at significantly varying rates. See https://t.co/xGyGlLD30i
RT @maier_larissa: The high demand for ecstasy tablets, professional drug checking services, & other quality control measures have resulted…
New drug-testing paper: a lot of variability in dosage and release time within single batches of MDMA/ecstasy. Therefore, doses from the same batch may have different effects https://t.co/rzPvu0Ba9I https://t.co/ktZ3og2HgV
RT @maier_larissa: The high demand for ecstasy tablets, professional drug checking services, & other quality control measures have resulted…
RT @maier_larissa: The high demand for ecstasy tablets, professional drug checking services, & other quality control measures have resulted…
Variability in content and dissolution profiles of MDMA tablets collected in the UK between 2001 and 2018 – a potential risk to users? - Couchman - - Drug Testing and Analysis - Wiley Online Library https://t.co/qWXlHhyaNo
RT @maier_larissa: The high demand for ecstasy tablets, professional drug checking services, & other quality control measures have resulted…
RT @maier_larissa: The high demand for ecstasy tablets, professional drug checking services, & other quality control measures have resulted…
The high demand for ecstasy tablets, professional drug checking services, & other quality control measures have resulted in high-content tablets produced/sold in EU countries. Varying content & dissolution profiles put PWUD at risk, regulation could help! https://t.co/NBGyfTGuOC
New MDMA paper from LTG members: https://t.co/KGA21pD3Rd
RT @claudiovidalg: This study addresses an important question I have thinking of a lot. Ecstasy tablets from a same batch could not contain…
RT @claudiovidalg: This study addresses an important question I have thinking of a lot. Ecstasy tablets from a same batch could not contain…
RT @claudiovidalg: This study addresses an important question I have thinking of a lot. Ecstasy tablets from a same batch could not contain…
This study addresses an important question I have thinking of a lot. Ecstasy tablets from a same batch could not contain the same amount of MDMA because the illicit nature of their production (lack of quality control). https://t.co/LoNp55mMGv https://t.co/1oBTnPWigQ
From the paper: "For MDMA users, our data suggest that analysis of a single tablet from a batch cannot guarantee that all others in the same batch are of the same content." https://t.co/htFvGr7vVt
TABLE 5 Standard addition method for the determination of tram- 5(7), 2605–2610. ... Drug Testing and Analysis, 9, 1243–1250. https://doi.org/10.1002/dta.2157 ...
10.1002/dta.1975. Fritschi G, Klein B (1995) Zwischen- und nebenproduckte bei ... 2605–2628. Glennon RA, Young R (2011) Drug discrimination: applications ...
10.1002/dta.1686; BRODIE RR, 1981, BIOPHARM DRUG DISPOS, V2, P59, DOI ... 2605-z; Haberstick BC, 2014, DRUG ALCOHOL DEPEN, V136, P158, DOI 10.1016/j ...
https://doi.org/10.1002/hrm.22221 #Masking #Neurodivergente ... Eisenberg, D. T. A., Campbell, B., Gray, P. B., & Sorenson, M. D. ...
2605Me gusta. 10Comentarios. 472Veces compartido. elrealcontenido8 ... doi: 10.1002/dta.2036. . Heidemann LA, et al. Severe Acute ...
provided DTA mice. D.P. analyzed data and wrote the manuscript with ... Blood 125, 2605–2614 (2015). GO TO REFERENCE. Crossref · PubMed.
... 2605 architectural requirements under client's bespoke warranty conditions. ... 10.1002/adfm. 200700902/abstract The Dr. Younan Xia Group ...
These data reveal genetic risk loci of cancer predisposition as active DNA regulatory elements in cancer, identify gene-regulatory interactions ...
... 2605 architectural requirements under client's bespoke warranty conditions. Graphecoat line of products are based on the Cubson's well ...
LP
CV
JP
PH
LB
AI
AJ
S
CA
EH
NK
JH
H
JG
A
SB